Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders

Ballatore, Carlo, Lee, Virginia M.-Y., Trojanowski, John Q.·2007·Nature Reviews Neuroscience

Cited by (1,013)

Items 801–900 of 1,013

  1. Functional roles of circular RNAs in Alzheimer’s disease
    Jin-Lan Huang, Min Su, Deng‐Pan Wu · 2020 · Ageing Research Reviews
  2. Abnormal tau phosphorylation in primary progressive multiple sclerosis
    Jane Marian Anderson, Rickie Patani, Richard Reynolds, Richard S. Nicholas, Alastair Compston, Maria Grazia Spillantini, Siddharthan Chandran · 2010 · Acta Neuropathologica
  3. Global Analysis of Phosphorylation of Tau by the Checkpoint Kinases Chk1 and Chk2 in vitro
    Jhoana Mendoza, Michiko Sekiya, Taizo Taniguchi, Koichi Iijima, Rong Wang, Kanae Ando · 2013 · Journal of Proteome Research
  4. Targeting insulin-like growth factor-1 to treat Alzheimer's disease
    Ignacio Torres‐Alemán · 2007 · Expert Opinion on Therapeutic Targets
  5. Synthesis of Thiophene‐Based Optical Ligands That Selectively Detect Tau Pathology in Alzheimer's Disease
    Hamid Shirani, Hanna Appelqvist, Marcus Bäck, Therése Klingstedt, Nigel J. Cairns, K. Peter R. Nilsson · 2017 · Chemistry - A European Journal
  6. Poly (ADP-ribose) polymerase 1 and neurodegenerative diseases: past, present, and future
    Hu, Meng-Ling, Pan, Yi-Ru, Yong, Yuan-Yuan, Liu, Yi, Yu, Lu, Qin, Da-Lian, Qiao, Gan, Law, Betty Yuen-Kwan, Wu, Jian-Ming, Zhou, Xiao-Gang et al. · 2023 · Ageing Research Reviews
  7. Astaxanthin enhances autophagy, amyloid beta clearance and exerts anti-inflammatory effects in in vitro models of Alzheimer’s disease-related blood brain barrier dysfunction and inflammation
    Joshua Adekunle Babalola, Magdalena Lang, Meekha George, Anika Stracke, Carmen Tam‐Amersdorfer, Izaskun Itxaso, Domjan Lucija, Jelena Tadić, Irene Schilcher, Tina Loeffler et al. · 2023 · Brain Research
  8. Isolation and Biochemical Characterization of Amyloid Plaques and Paired Helical Filaments
    Agueda A. Rostagno, Jorge A. Ghiso · 2009 · Current Protocols in Cell Biology
  9. Identification of a major radiometabolite of [ 11 C]PBB3
    Hiroki Hashimoto, Kazunori Kawamura, Makoto Takei, Nobuyuki Igarashi, Tomoya Fujishiro, Satoshi Shiomi, Ryuji Watanabe, Masatoshi Muto, Kenji Furutsuka, Takehito Ito et al. · 2015 · Nuclear Medicine and Biology
  10. Synthesis and structure-activity relationship of 4-(1,3-benzothiazol-2-yl)-thiophene-2-sulfonamides as cyclin-dependent kinase 5 (cdk5)/p25 inhibitors
    Jonas Malmström, Jenny Viklund, Can Slivo, Ana Costa, Mickaël Maudet, Catrin Sandelin, Gösta Hiller, Lise‐Lotte Olsson, Anna Aagaard, Stefan Geschwindner et al. · 2012 · Bioorganic & Medicinal Chemistry Letters
  11. Advances in tau-based drug discovery
    Wendy J. Noble, Amy M. Pooler, Diane P. Hanger · 2011 · Expert Opinion on Drug Discovery
  12. Modulation of Protein-Protein Interactions as a Therapeutic Strategy for the Treatment of Neurodegenerative Tauopathies
    Carlo Ballatore, Kurt R. Brunden, John Q. Trojanowski, V. M. -Y. Lee, Amos B. Smith, Donna M. Huryn · 2010 · Current Topics in Medicinal Chemistry
  13. G2019S LRRK2 enhances the neuronal transmission of tau in the mouse brain
    An Phu Tran Nguyen, Guillaume Daniel, Pamela Valdés, Md. Shariful Islam, Bernard Laurent Schneider, Darren J. Moore · 2017 · Human Molecular Genetics
  14. Tau/MAPT disease-associated variant A152T alters tau function and toxicity via impaired retrograde axonal transport
    Victoria J. Butler, Dominique A Salazar, David Soriano‐Castell, Miguel Alves‐Ferreira, Frank J.A. Dennissen, Mihir Vohra, Juan A. Osés-Prieto, Kathy H. Li, Austin L Wang, Beibei Jing et al. · 2018 · Human Molecular Genetics
  15. Neuroprotective Effects of HSF1 in Retinal Ischemia-Reperfusion Injury
    Wei Liu, Fan Xia, Yonju Ha, Shuang Zhu, Yi Li, Oluwarotimi O. Folorunso, Aryan Pashaei-Marandi, Pei-Yi Lin, Ronald G. Tilton, Anson P. Pierce et al. · 2019 · Investigative Ophthalmology & Visual Science
  16. Activity of the poly(A) binding protein MSUT2 determines susceptibility to pathological tau in the mammalian brain
    Jeanna M. Wheeler, Pamela J. McMillan, Timothy J. Strovas, Nicole F. Liachko, Alexandre Amlie‐Wolf, Rebecca L. Kow, Ronald L. Klein, Patricia Szot, Linda Robinson, Chris R. Guthrie et al. · 2019 · Science Translational Medicine
  17. Defining and predicting transdiagnostic categories of neurodegenerative disease
    Eli J. Cornblath, John L. Robinson, David John Irwin, Edward B. Lee, Virginia M.‐Y. Lee, John Q. Trojanowski, Danielle S. Bassett · 2020 · Nature Biomedical Engineering
  18. Destabilization potential of phenolics on Aβ fibrils: mechanistic insights from molecular dynamics simulation
    Shivani Gupta, Ashok Kumar Dasmahapatra · 2020 · Physical Chemistry Chemical Physics
  19. Disulfide bond formation in microtubule-associated tau protein promotes tau accumulation and toxicity in vivo
    Taro Saito, Tomoki Chiku, Mikiko Oka, Satoko Wada‐Kakuda, Mika Nobuhara, Toshiya Oba, Kanako Shinno, Saori Abe, Akiko Asada, Akio Sumioka et al. · 2021 · Human Molecular Genetics
  20. A Survey on Computational Methods in Drug Discovery for Neurodegenerative Diseases
    Caterina Vicidomini, Francesco Fontanella, Tiziana D’Alessandro, Giovanni Nicola Roviello · 2024 · Biomolecules
  21. Potential Therapeutical Contributions of the Endocannabinoid System towards Aging and Alzheimer’s Disease
    Amandine EB, Yannick Marchalant · 2015 · Aging and Disease
  22. γ-Aminobutyric Acid Type A (GABAA) Receptor Activation Modulates Tau Phosphorylation
    Niko-Petteri Nykänen, Kai Kysenius, Prasanna Sakha, Päivi Tammela, Henri J. Huttunen · 2012 · Journal of Biological Chemistry
  23. Phosphorylation of more than one site is required for tight interaction of human tau protein with 14‐3‐3ζ
    Nikolai N. Sluchanko, Alim S. Seit‐Nebi, Nikolai B. Gusev · 2009 · FEBS Letters
  24. ANK1 is up-regulated in laser captured microglia in Alzheimer’s brain; the importance of addressing cellular heterogeneity
    Diego Mastroeni, Shobana Sekar, Jennifer Nolz, Elaine Delvaux, Katie Lunnon, Jonathan S. Mill, Winnie S. Liang, Paul D. Coleman · 2017 · PLoS ONE
  25. The structure and phase of tau: from monomer to amyloid filament
    Yifan Zeng, Jing Yang, Bailing Zhang, Meng Gao, Zhengding Su, Yongqi Huang · 2020 · Cellular and Molecular Life Sciences
  26. Natural Compounds for SIRT1‐Mediated Oxidative Stress and Neuroinflammation in Stroke: A Potential Therapeutic Target in the Future
    Chaoyou Fang, Houshi Xu, Ling Yuan, Zhengyang Zhu, Xiaoyu Wang, Yibo Liu, Anke Zhang, Anwen Shao, Meiqing Lou · 2022 · Oxidative Medicine and Cellular Longevity
  27. Loss of calbindin-D 28K is associated with the full range of tangle pathology within basal forebrain cholinergic neurons in Alzheimer's disease
    Saman Seyed Ahmadian, Aras Rezvanian, Melanie Peterson, Sandra Weıntraub, Eileen H. Bigio, Marsel M. Mesulam, Changiz Geula · 2015 · Neurobiology of Aging
  28. Resonance Raman Spectroscopic Measurements Delineate the Structural Changes that Occur during Tau Fibril Formation
    Gayathri Ramachandran, Erix Alexander Milán‐Garcés, Jayant B. Udgaonkar, Mrinalini Puranik · 2014 · Biochemistry
  29. The Triple Alliance: Microbiome, Mitochondria, and Metabolites in the Context of Age-Related Cognitive Decline and Alzheimer’s Disease
    Santosh Kumar Prajapati, Ria Shah, Nicholas Alford, Sidharth Prasad Mishra, Shalini Jain, BARBARA CALEEN HANSEN, Paul R. Sanberg, Anthony J. A. Molina, Hariom Yadav · 2023 · The Journals of Gerontology Series A
  30. Statins: The Role in the Treatment and Prevention of Alzheimer's Neurodegeneration
    Chen Pac-Soo, Dafydd G. Lloyd, Marcela Paola Vizcaychipi, Daqing Ma · 2011 · Journal of Alzheimer s Disease
  31. Initiation and propagation of neurodegeneration
    Christian Haass · 2010 · Nature Medicine
  32. Calcium Ions Stimulate the Hyperphosphorylation of Tau by Activating Microsomal Prostaglandin E Synthase 1
    Long‐Long Cao, Pei-Pei Guan, Yun-Yue Liang, Xueshi Huang, Pu Wang · 2019 · Frontiers in Aging Neuroscience
  33. 14-3-3/Tau Interaction and Tau Amyloidogenesis
    Yuwen Chen, Xingyu Chen, Zhiyang Yao, Yuqi Shi, Junwen Xiong, Jingjing Zhou, Zhengding Su, Yongqi Huang · 2019 · Journal of Molecular Neuroscience
  34. Caffeine destabilizes preformed Aβ protofilaments: insights from all atom molecular dynamics simulations
    Shivani Gupta, Ashok Kumar Dasmahapatra · 2019 · Physical Chemistry Chemical Physics
  35. Tau Related Pathways as a Connecting Link between Epilepsy and Alzheimer’s Disease
    Yam Nath Paudel, Efthalia Angelopoulou, Nigel C. Jones, Terence John O'Brien, Patrick Kwan, Christina Piperi, Iekhsan Othman, Mohd. Farooq Shaikh · 2019 · ACS Chemical Neuroscience
  36. Microtubule affinity–regulating kinase 4 with an Alzheimer's disease-related mutation promotes tau accumulation and exacerbates neurodegeneration
    Toshiya Oba, Taro Saito, Akiko Asada, Sawako Shimizu, Koichi Iijima, Kanae Ando · 2020 · Journal of Biological Chemistry
  37. Tau protein as a diagnostic and prognostic biomarker in amyotrophic lateral sclerosis
    Luisa Agnello, Tiziana Colletti, Bruna Lo Sasso, Matteo Vidali, Rossella Spataro, Caterina Maria Gambino, Rosaria Vincenza Giglio, Tommaso Piccoli, Giulia Bivona, Vincenzo La Bella et al. · 2021 · European Journal of Neurology
  38. miR-143-3p Inhibits Aberrant Tau Phosphorylation and Amyloidogenic Processing of APP by Directly Targeting DAPK1 in Alzheimer’s Disease
    Long Wang, Xindong Shui, Yingxue Mei, Yongfang Xia, Guihua Lan, Li Hu, Mi Zhang, Chen‐Ling Gan, Ruomeng Li, Yuan Tian et al. · 2022 · International Journal of Molecular Sciences
  39. Tau Protein Provides DNA with Thermodynamic and Structural Features which are Similar to those Found in Histone-DNA Complex
    Sergio Camero, María José Benítez, Alejandro Barrantes, José María Ayuso, Raquel Cuadros, Jesús Ávila, Juan S. Jiménez · 2014 · Journal of Alzheimer s Disease
  40. Depletion of CXCR2 inhibits γ-secretase activity and amyloid-β production in a murine model of Alzheimer’s disease
    Pancham Bakshi, Elaina Margenthaler, Jon M. Reed, Fiona Crawford, MICHAEL J. MULLAN · 2010 · Cytokine
  41. Role of tau in the spatial organization of axonal microtubules: keeping parallel microtubules evenly distributed despite macromolecular crowding
    Alix Méphon-Gaspard, Mirela Boca, Catherine Pioche‐Durieu, Bénédicte Desforges, Andrea Burgo, Loïc Hamon, Olivier Piétrement, David Pastré · 2016 · Cellular and Molecular Life Sciences
  42. Tau–RNA complexes inhibit microtubule polymerization and drive disease-relevant conformation change
    Pamela J. McMillan, Sarah J. Benbow, Rikki L. Uhrich, Aleen D. Saxton, Misa Baum, Timothy J. Strovas, Jeanna M. Wheeler, Jeremy D. Baker, Nicole F. Liachko, Christopher Dirk Keene et al. · 2023 · Brain
  43. p-tau Ser356 is associated with Alzheimer’s disease pathology and is lowered in brain slice cultures using the NUAK inhibitor WZ4003
    Lewis W. Taylor, Elizabeth M. Simzer, Claire Pimblett, Oscar T. T. Lacey-Solymar, Robert I. McGeachan, Soraya Meftah, Jamie L. Rose, Maxwell P Spires-Jones, Kristján Holt, James H. Catterson et al. · 2024 · Acta Neuropathologica
  44. Roles of TREM2 in the Pathological Mechanism and the Therapeutic Strategies of Alzheimer's Disease
    Min Lin, Jingjing Yu, Wenwei Zhang, Fengxue Lao, He Huang · 2024 · The Journal of Prevention of Alzheimer s Disease
  45. Human and mouse proteomics reveals the shared pathways in Alzheimer’s disease and delayed protein turnover in the amyloidome
    Yarbro, Jay M., Han, Xian, Dasgupta, Abhijit, Yang, Ka, Liu, Danting, Shrestha, Him K., Zaman, Masihuz, Wang, Zhen, Yu, Kaiwen, Lee, Dong Geun et al. · 2025 · Nature Communications
  46. Cerebrospinal Fluid Levels of a 20–22 kDa NH2 Fragment of Human Tau Provide a Novel Neuronal Injury Biomarker in Alzheimer's Disease and Other Dementias
    Giuseppina Amadoro, Veronica Corsetti, Giulia Maria Sancesario, Adele Lubrano, Gaia Melchiorri, Sergio Bernardini, Pietro Calissano, Giuseppe Sancesario · 2014 · Journal of Alzheimer s Disease
  47. A peptidyl–prolyl isomerase, FKBP12, accumulates in Alzheimer neurofibrillary tangles
    Hisato Sugata, Kazuhiko Matsuo, Taisuke Nakagawa, Mikiko Takahashi, Hideyuki Mukai, Yoshitaka Ono, Kiyoshi Maeda, Haruhiko Akiyama, Toshio Kawamata · 2009 · Neuroscience Letters
  48. Alteration of the Wnt/GSK3β/β‑catenin signalling pathway by rapamycin ameliorates pathology in an Alzheimer's disease model
    Jingfei Chen, Zhimin Long, Yanzhen Li, Min Luo, Shifang Luo, Guiqiong He · 2019 · International Journal of Molecular Medicine
  49. Longitudinal Association of Total Tau Concentrations and Physical Activity With Cognitive Decline in a Population Sample
    Pankaja Desai, Denis A. Evans, Klodian Dhana, Neelum T. Aggarwal, Robert S. Wilson, Elizabeth A. McAninch, Kumar Bharat Rajan · 2021 · JAMA Network Open
  50. Insights into the molecular interactions between aminopeptidase and amyloid beta peptide using molecular modeling techniques
    Maruti Jayram Dhanavade, Kailas Dasharath Sonawane · 2014 · Amino Acids
  51. FRMD4A–cytohesin signaling modulates the cellular release of tau
    Xu Yan, Niko-Petteri Nykänen, Cecilia Anna Brunello, Annakaisa Haapasalo, Mikko O. Hiltunen, Riikka‐Liisa Uronen, Henri J. Huttunen · 2016 · Journal of Cell Science
  52. The GABAergic septohippocampal connection is impaired in a mouse model of tauopathy
    Helena Soler, Jonatan Dorca‐Arévalo, Marta González, Sara E. Rubio, Jesús Ávila, Eduardo Soriano, Marta Pascual · 2016 · Neurobiology of Aging
  53. Nuclear Receptors, Inflammation, and Neurodegenerative Diseases
    Kaoru Saijo, Andrea Crotti, Christopher K. Glass · 2010 · Advances in immunology
  54. The inhibitory effect of Curcumin-Artemisinin co-amorphous on Tau aggregation and Tau phosphorylation
    Tushar Dubey, Shweta Kishor Sonawane, M. K. Chaitanya Mannava, Ashwini Kumar Nangia, Madhura Chandrashekar, Subashchandrabose Chinnathambi · 2022 · Colloids and Surfaces B Biointerfaces
  55. Pathophysiological Role of Microglial Activation Induced by Blood-Borne Proteins in Alzheimer’s Disease
    Sehwan Kim, Chanchal Sharma, Un Ju Jung, Sang Ryong Kim · 2023 · Biomedicines
  56. Combination of PKCε Activation and PTP1B Inhibition Effectively Suppresses Aβ-Induced GSK-3β Activation and Tau Phosphorylation
    Takeshi Kanno, Ayako Tsuchiya, Akito Tanaka, Tomoyuki Nishizaki · 2015 · Molecular Neurobiology
  57. The exploration of thienothiazines as selective butyrylcholinesterase inhibitors
    Daniela Karlsson, Adyary Fallarero, Gerda Brunhofer, Claudia Mayer, Ohm Prakash, C. Gopi Mohan, Pia Maarit Vuorela, Thomas Erker · 2012 · European Journal of Pharmaceutical Sciences
  58. Disinhibition-like behavior in a P301S mutant tau transgenic mouse model of frontotemporal dementia
    Magdalena Przybyla, Claire H. Stevens, Julia van der Hoven, Anne E. Harasta, Mian Bi, Arne Ittner, Annika van Hummel, John R. Hodges, Olivier Piguet, Tim Karl et al. · 2016 · Neuroscience Letters
  59. Quercetin inhibits okadaic acid-induced tau protein hyperphosphorylation through the Ca2+‑calpain‑p25‑CDK5 pathway in HT22 cells
    Xiu‐Yin Shen, Tao Luo, Sheng Li, Ouyang Ting, Feng He, Jie Xu, Huaqiao Wang · 2017 · International Journal of Molecular Medicine
  60. Tau isoform expression and phosphorylation in marmoset brains
    Govinda Sharma, Anni Huo, Taeko Kimura, Seiji Shiozawa, Reona Kobayashi, Naruhiko Sahara, Minaka Ishibashi, Shinsuke Ishigaki, Taro Saito, Kanae Ando et al. · 2019 · Journal of Biological Chemistry
  61. The Pathophysiology of Tau and Stress Granules in Disease
    Anna Lourdes Cruz, Mamta Verma, Benjamin L. Wolozin · 2019 · Advances in experimental medicine and biology
  62. Light sheet fluorescence microscopy of optically cleared brains for studying the glymphatic system
    Nicholas Burdon Bèchet, Tekla Maria Kylkilahti, Bengt Mattsson, Martina Petrášová, Nagesh C. Shanbhag, Iben Lundgaard · 2020 · Journal of Cerebral Blood Flow & Metabolism
  63. Non-Invasive RF Technique for Detecting Different Stages of Alzheimer’s Disease and Imaging Beta-Amyloid Plaques and Tau Tangles in the Brain
    Imran Saied, Tughrul Arslan, Siddharthan Chandran, Colin Smith, Tara L. Spires‐Jones, Suvankar Pal · 2020 · IEEE Transactions on Medical Imaging
  64. Nuclear Transport Deficits in Tau-Related Neurodegenerative Diseases
    Lisa Diez, Susanne Wegmann · 2020 · Frontiers in Neurology
  65. Die Alzheimer‐Demenz: von der Pathologie zu therapeutischen Ansätzen
    Roland Jakob‐Roetne, Helmut Jacobsen · 2009 · Angewandte Chemie
  66. Combinatorial Tau Pseudophosphorylation
    Erkan Kiris, Donovan Ventimiglia, Mehmet Emre Sargin, Michelle R. Gaylord, Alphan Altınok, Kenneth H. Rose, B. S. Manjunath, Mary Ann Jordan, Leslie Wilson, Stuart C. Feinstein · 2011 · Journal of Biological Chemistry
  67. Tau/PTL-1 associates with kinesin-3 KIF1A/UNC-104 and affects the motor's motility characteristics in C. elegans neurons
    Nai-Wen Tien, Gong‐Her Wu, Chih-Chun Hsu, Chien-Yu Chang, Oliver Ingvar Wagner · 2011 · Neurobiology of Disease
  68. Introduction to Protein Structure
    Gerhard Meisenberg, William H. Simmons · 2012 · Elsevier eBooks
  69. When the infectious environment meets the AD brain
    Ganz, Tal, Fainstein, Nina, Ben-Hur, Tamir · 2022 · Molecular Neurodegeneration
  70. The propagation mechanisms of extracellular tau in Alzheimer’s disease
    Yun Wei, Meixia Liu, Dong‐Xin Wang · 2021 · Journal of Neurology
  71. Tau target identification reveals NSF‐dependent effects on AMPA receptor trafficking and memory formation
    Emmanuel Prikas, Esmeralda Parić, Prita Riana Asih, Kristie Stefanoska, Holly Stefen, Thomas Fath, Anne Poljak, Arne Ittner · 2022 · The EMBO Journal
  72. Anti-amyloid-β Antibodies and Anti-tau Therapies for Alzheimer’s Disease: Recent Advances and Perspectives
    Naoyuki Suzuki, Takuya Hatta, Mana Ito, Ken‐ichi Kusakabe · 2024 · Chemical and Pharmaceutical Bulletin
  73. Regulation of protein conformation by Pin1 offers novel disease mechanisms and therapeutic approaches in Alzheimer's disease.
    Jane Ann Driver, Xiao Zhen Zhou, Kun Ping Lu · 2014 · PubMed
  74. TTBK2: A Tau Protein Kinase beyond Tau Phosphorylation
    Jung‐Chi Liao, T. Tony Yang, Rueyhung Roc Weng, Ching‐Te Kuo, Chih‐Wei Chang · 2015 · BioMed Research International
  75. Accelerated aging exacerbates a pre‐existing pathology in a tau transgenic mouse model
    Liviu‐Gabriel Bodea, Harrison Tudor Evans, Ann Van der Jeugd, Lars Matthias Ittner, Fabien Delerue, Jillian J. Kril, Glenda Margaret Halliday, John R. Hodges, Matthew C. Kiernan, Jürgen Götz · 2017 · Aging Cell
  76. Design, synthesis, in vitro and in vivo evaluation of tacrine–cinnamic acid hybrids as multi-target acetyl- and butyrylcholinesterase inhibitors against Alzheimer's disease
    Yao Chen, Hongzhi Lin, Jie Zhu, Kai Gu, Qi Li, Siyu He, Xin Lü, Ren Xiang Tan, Yuqiong Pei, Liang Wu et al. · 2017 · RSC Advances
  77. Accelerated kindling epileptogenesis in Tg4510 tau transgenic mice, but not in tau knockout mice
    Shijie Liu, Yu Shen, Sandy R. Shultz, Anne Nguyen, Christopher M. Hovens, Paul Anthony Adlard, Ashley Ian Bush, Jianxiong Chan, Patrick Kwan, Terence John O'Brien et al. · 2017 · Epilepsia
  78. Biomolecular condensation of the microtubule-associated protein tau
    Tina Ukmar, Susanne Wegmann, Markus Zweckstetter · 2019 · Seminars in Cell and Developmental Biology
  79. Potent Tau Aggregation Inhibitor D‐Peptides Selected against Tau‐Repeat 2 Using Mirror Image Phage Display
    Marwa Malhis, Senthilvelrajan Kaniyappan, Isabelle Aillaud, RamReddy Chandupatla, Lisa Marie Ramirez, Markus Zweckstetter, Anselm H. C. Horn, Eckhard Mandelkow�, Heinrich Sticht, Susanne Aileen Funke · 2021 · ChemBioChem
  80. Arc Regulates Transcription of Genes for Plasticity, Excitability and Alzheimer’s Disease
    How-Wing Leung, Gabriel Foo, Antonius M.J. VanDongen · 2022 · Biomedicines
  81. Total tau is increased, but phosphorylated tau not decreased, in cerebrospinal fluid in amyotrophic lateral sclerosis
    Carlo Wilke, Christian Deuschle, Tim W. Rattay, Walter Maetzler, Matthis Synofzik · 2014 · Neurobiology of Aging
  82. Pseudophosphorylation of tau protein directly modulates its aggregation kinetics
    Edward Chang, Sohee Kim, Kelsey N. Schafer, Jeff Kuret · 2010 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
  83. Reduction of the RNA Binding Protein TIA1 Exacerbates Neuroinflammation in Tauopathy
    Chelsey Jenna LeBlang, Maria Medalla, Nicholas William Nicoletti, Emma Catherine Hays, James Zhao, Jenifer E. Shattuck, Anna Lourdes Cruz, Benjamin L. Wolozin, Jennifer Irene Luebke · 2020 · Frontiers in Neuroscience
  84. Molecular rules governing the structural polymorphism of amyloid fibrils in neurodegenerative diseases
    Dan Li, Cong Liu · 2023 · Structure
  85. Female Hippocampus Vulnerability to Environmental Stress, a Precipitating Factor in Tau Aggregation Pathology
    Ioannis Sotiropoulos, Joana Margarida Silva, Tetsuya Kimura, Ana João Rodrigues, Patrí­cio Costa, Osborne F. X. Almeida, Nuno Sousa, Akihiko Takashima · 2014 · Journal of Alzheimer s Disease
  86. Yeast as a Model System to Study Tau Biology
    Ann De Vos, Jayamani Anandhakumar, Jeff Van den Brande, Mathias Verduyckt, Vanessa Franssens, Joris Winderickx, Erwin Swinnen · 2011 · International Journal of Alzheimer s Disease
  87. Microtubule Dynamicity Is More Important than Stability in Memory Formation: an In Vivo Study
    Deyhim Atarod, Ghazaleh Eskandari‐Sedighi, Farid Pazhoohi, Seyed Morteza Karimian, Mojtaba Khajeloo, Gholam Hossein Riazi · 2015 · Journal of Molecular Neuroscience
  88. Identification of Ligands for the Tau Exon 10 Splicing Regulatory Element RNA by Using Dynamic Combinatorial Chemistry
    Paula López‐Senín, Irene Gómez‐Pinto, Anna Grandas, Vicente Marchán · 2011 · Chemistry - A European Journal
  89. Mutant human APP exacerbates pathology in a mouse model of NPC and its reversal by a β-cyclodextrin
    Mahua Maulik, Bibaswan Ghoshal, John Kim, Yanlin Wang, Jing Yang, David A. Westaway, Satyabrata Kar · 2012 · Human Molecular Genetics
  90. Involvement of tau phosphorylation in traumatic brain injury patients
    W-J. Yang, W. Chen, Lie Chen, Y-J. Guo, J-S. Zeng, G-Y. Li, W-S. Tong · 2016 · Acta Neurologica Scandinavica
  91. The Polyphenol Altenusin Inhibits in Vitro Fibrillization of Tau and Reduces Induced Tau Pathology in Primary Neurons
    Sook Wern Chua, Alberto Cornejo, Janet van Eersel, Claire H. Stevens, Inmaculada Vaca, Mercedes Cueto, Michael Kassiou, Amadeus Gladbach, Alex Macmillan, Lev Lewis et al. · 2017 · ACS Chemical Neuroscience
  92. Tau Pathology Promotes the Reorganization of the Extracellular Matrix and Inhibits the Formation of Perineuronal Nets by Regulating the Expression and the Distribution of Hyaluronic Acid Synthases
    Yin Li, Zexu Li, Tan Jin, Zhan‐You Wang, Pu Zhao · 2017 · Journal of Alzheimer s Disease
  93. Polymorphic α-Synuclein Strains Modified by Dopamine and Docosahexaenoic Acid Interact Differentially with Tau Protein
    Urmi Sengupta, Nicha Puangmalai, Nemil N. Bhatt, Stephanie García, Yingxin Zhao, Rakez Kayed · 2020 · Molecular Neurobiology
  94. The Two Cysteines of Tau Protein Are Functionally Distinct and Contribute Differentially to Its Pathogenicityin Vivo
    Engie Prifti, Eleni N. Tsakiri, Ergina Vourkou, George M. Stamatakis, Martina K. Samiotaki, Katerina Papanikolopoulou · 2020 · Journal of Neuroscience
  95. Nucleic acids as templates and catalysts in chemical reactions: target-guided dynamic combinatorial chemistry and in situ click chemistry and DNA/RNA induced enantioselective reactions
    Puja Saha, Deepanjan Panda, Jyotirmayee Dash · 2023 · Chemical Society Reviews
  96. Effects of PTEN inhibition on regulation of tau phosphorylation in an okadaic acid‐induced neurodegeneration model
    Zhou Chen, Bin Chen, Wenfang Xu, Rong‐Fang Liu, Jian Yang, Chang‐Xi Yu · 2012 · International Journal of Developmental Neuroscience
  97. Vibrational spectroscopic analysis of peripheral blood plasma of patients with Alzheimer’s disease
    P. Carmona, Marina Molina, Eduardo López‐Tobar, A. Tolédano · 2015 · Analytical and Bioanalytical Chemistry
  98. Evidence for Prion-Like Mechanisms in Several Neurodegenerative Diseases: Potential Implications for Immunotherapy
    Kristen Marciniuk, Ryan Taschuk, Scott Napper · 2013 · Clinical and Developmental Immunology
  99. Evidence for abnormal tau phosphorylation in early aggressive multiple sclerosis
    Jane Marian Anderson, Rickie Patani, Richard Reynolds, Richard S. Nicholas, Alastair Compston, Maria Grazia Spillantini, Siddharthan Chandran · 2009 · Acta Neuropathologica
  100. Brain-Defective Insulin Signaling Is Associated to Late Cognitive Impairment in Post-Septic Mice
    Fernanda Neves, Patrícia T. Marques, Fernanda G. Q. Barros‐Aragão, José Bruno Nunes, Aline M. Venancio, Danielle Cozachenco, Rudimar Luiz Frozza, Giselle Fazzioni Passos, Robson da Costa, Jade de Oliveira et al. · 2016 · Molecular Neurobiology